| pubmed-article:7824558 | pubmed:abstractText | Twenty-five Sprague-Dawley rats were implanted with electrodes for standard sleep-wake cycle recordings. A guide cannula was stereotaxically implanted into the lateral ventricle. Rats were divided into five groups (n = 5) and challenged with an intraventricular administration of 10 microliters of a 5 nM solution of either: ethanol (EtOH), MK-801, AP5 (noncompetitive and competitive NMDA receptor antagonists, respectively), CNQX (AMPA receptor antagonist), or saline. Rats were recorded polygraphically for the following 4 h. Results showed that, at comparable doses, all tested drugs reduced REM sleep. No significant changes were detected in slow-wave sleep or wakefulness. This selective effect of glutamatergic antagonists suggests that glutamate may be a selective modulator of REM sleep. These findings also show that EtOH shares similar pharmacological effects on the sleep-wake cycle of the rat. Ultimately, glutamatergic mechanisms could contribute to the EtOH-mediated reduction of REM sleep. | lld:pubmed |
